Susan Hubbard | EVP, Public Affairs and IR |
Mike Morrissey | President and CEO |
Chris Senner | CFO |
P.J. Haley | EVP, Commercial |
Vicki Goodman | Chief Medical Officer |
Peter Lamb | Chief Scientific Officer |
Asthika Goonewardene | Truist Securities |
Michael Schmidt | Guggenheim |
Geoffrey Weiner | Credit Suisse |
Jason Gerberry | Bank of America |
Andy Hsieh | William Blair |
Etzer Darout | BMO Capital Markets |
Yaron Werber | Cowen |
Peter Lawson | Barclays |
Silvan Tuerkcan | JMP Securities |
Mike King | EF Hutton |
Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Vaishnavi, and I’ll be your operator for today.
As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations.